Adding brentuximab vedotin to chemotherapy in pediatric Hodgkin lymphoma produced results that have been hailed as a paradigm shift and have just led to FDA approval for this new indication.
PORTLAND, Ore., Jan. 14, 2021 /PRNewswire/ Cambia Health Foundation announces the seventh cohort of scholars accepted into its Sojourns® Scholar Leadership Program. Twelve emerging palliative care leaders were carefully chosen through a rigorous selection process from a highly competitive pool. In addition, the Foundation has opened the 2021 Sojourns® Scholar Leadership Program Call for Applications and encourages palliative care professionals from across the country, including all disciplines and practice settings to apply.
ADVERTISEMENT
The Sojourns Scholar Leadership Program is designed to identify, cultivate and advance the next generation of palliative care leaders. As part of the leadership program, each Sojourns Scholar receives $180,000 in funding ($90,000/year over a two-year period) to conduct an innovative and impactful clinical, policy, educational, health equity or systems change project in the field of palliative care. Scholars also participate with other scholars